Y Lynn Wang
10PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 09, 2022
SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker.Wenjun Wu, Pin Lu, Priyal Patel
|Aug 27, 2022
Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.Shazia Nakhoda, Aldana Vistarop, Y Lynn Wang
|Feb 19, 2021
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.Pin Lu, Shengchun Wang, Carrie A Franzen
|Mar 14, 2019
Metabolic Detection of Bruton's Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells.Seung-Cheol Lee, Alexander A Shestov, Lili Guo
|Dec 05, 2018
XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB.Mei Ming, Wenjun Wu, Bingqing Xie
|Oct 19, 2018
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.Greg P Coffey, Jiajia Feng, Andreas Betz
Pageof 2
Frequent Collaborators
2 joint publications
Jimmy Lee
2 joint publications
Natalie Galanina
2 joint publications
Madina Sukhanova
1 joint publications
Sabah Kadri
1 joint publications
Carrie Fitzpatrick
1 joint publications
Girish Venkataraman
1 joint publications
Brad Long
1 joint publications
Wenjun Kang
1 joint publications
Michael Thirman
1 joint publications
Sonali M Smith
